Expanded Access to Everolimus, for an Individual Patient With GIST (Gastrointestinal Stromal Tumors)(CTMS#18-0019)
Purpose
Single patient treatment with everolimus.
Condition
- Gastrointestinal Stromal Tumor
Eligibility
- Eligible Ages
- Over 18 Years
- Eligible Genders
- Female
- Accepts Healthy Volunteers
- No
Study Design
- Phase
- Study Type
- Expanded Access
More Details
- Status
- Temporarily not available
- Sponsor
- The University of Texas Health Science Center at San Antonio